Laxmi Dental Limited Posts ₹318.34 Million Net Profit in FY25; Revenue Grows by 24.1% Year-on-Year
By Ankur Chandra | Updated at: May 31, 2025 10:45 PM IST
MUMBAI, May 27, 2025: Laxmi Dental Limited (NSE: LAXMIDENTL | BSE: 544339) has reported its audited financial results for the fiscal year ended March 31, 2025, showcasing robust growth in revenue and profitability across both its standalone and consolidated operations.
Financial Performance Overview (₹ in Million)
| Particulars | FY25 | FY24 | YoY Growth |
|---|---|---|---|
| Consolidated Revenue from Operations | 2,365.63 | 1,914.50 | 23.6% |
| Consolidated Net Profit | 318.34 | 252.29 | 26.2% |
| Standalone Revenue | 1,691.57 | 1,378.78 | 22.7% |
| Standalone Net Profit | 243.54 | 32.23 | 656% |
| EPS (Consolidated – Basic) | ₹6.07 | ₹4.80 |
Segment-Wise Highlights
The Laboratory Business continues to be the company’s primary revenue driver, contributing ₹1,541.62 million, an increase of 18.6% compared to the previous year. The Aligners Business demonstrated exceptional growth of 42.4% year-on-year, recording revenue of ₹808.51 million. Conversely, revenue from Other Business segments saw a modest decline, falling to ₹149.45 million from ₹168.29 million in FY24.
Strategic Milestones in FY25
- Initial Public Offering (IPO) and Capital Expansion: Laxmi Dental successfully completed its IPO, issuing 16.3 million shares at a price of ₹428 per share. This included a fresh issue of 3.22 million shares. The total capital raised amounted to ₹1,380 million, with ₹1,281.70 million allocated for debt repayment, capital expenditure, and general corporate purposes. As of March 31, 2025, ₹950.33 million remains unutilised and has been invested in fixed deposits.
- Bonus Issue and Stock Split: The company expanded its equity base through a 1:17 bonus issue and by splitting each ₹10 share into five shares of ₹2 each.
- Employee Stock Ownership Plan (ESOP) 2024: Under its newly introduced ESOP plan, the company granted 351,672 options from a pool of 500,000 shares, strengthening its talent retention and incentive strategy.
Corporate Developments
- Business Divestment: During the fiscal year, Laxmi Dental completed the full divestment of its Alvy Dental Supply division.
- Exceptional Gain: The company recorded a one-time exceptional gain of ₹70.27 million (net of tax) arising from the sale of an investment property.
- Auditor Reappointment: M/s M. Jawadwala & Co. was reappointed as the Secretarial Auditor for FY26 to FY30, subject to shareholder approval.
Leadership Perspective
Reflecting on the year’s achievements, Sameer Kamlesh Merchant, Managing Director and CEO, stated,
“FY25 has been a pivotal year marked by strategic restructuring, a successful IPO, and exceptional operating results. Our consistent growth in both the laboratory and aligner segments reinforces our confidence in expanding our domestic and international footprint.”
Balance Sheet Snapshot
- Total Assets (Consolidated): ₹2,846.65 million, up from ₹1,345.23 million in the previous year
- Cash and Cash Equivalents: ₹185.42 million
- Net Worth: ₹2,085.37 million (Consolidated), ₹2,227.37 million (Standalone)
Future Outlook
With a well-established presence in dental prosthetics, aligners, and equipment, Laxmi Dental is strategically positioned to benefit from the evolving landscape of India’s oral care industry. Continued capital investments and a focus on operational efficiency are expected to sustain earnings momentum in the coming years.
No dividend has been declared for FY25. The company’s auditors have issued an unmodified opinion on both the standalone and consolidated financial statements.
REF: https://nsearchives.nseindia.com/corporate/LAXMI_27052025024115_Reg_30.pdf
